Cell and Gene Therapy 2021
Programme du congrès
While some developers are implementing lessons learned - and launching - their 2nd C and GTs to market, the majority are hoping the launch strategy for their 1st holds strong, as they navigate through a meteor shower of risky unknowns, firsts, new partnerships, and complexities the average pharma team has never experienced before.
Sélection de congrès
28ème Congrès annuel de l'American Society of Gene & Cell Therapy - ASGCT 2025
- Date : 13/05/2025
-
206
0